ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 163027 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 163027; 2) Community: the network communities that were significantly associated with the response to NSC 163027; 3) Molecule: the relationships between components within communities and NSC 163027; 4) MDR: the compounds that were significantly associated with the NSC 163027.

NSC Compound Enrichment Correlation
NSC 617823 4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride 0.00725424828633675 0.81958968
NSC 623639 Cyclopentane-1,3-dimethanamine, N,N,N,N',N',N'-hexamethyl-2-oxo-, iodide 0.00725424828633675 0.84172636
NSC 624172 Null 0.00725424828633675 0.60355918
NSC 630608 Null 0.00725424828633675 0.47204436
NSC 634785 4-Piperidinone, 1-[3-(diethylamino)-1-oxopropyl]-3,5-bis- (phenylmethylene)-, monohydrochloride 0.00725424828633675 0.44659054
NSC 639981 Null 0.00725424828633675 0.66851599
NSC 645330 11H-Benzo[a]carbazole-1,4-dione, 7,11-dimethyl- 0.00725424828633675 0.78155549
NSC 657270 (+/-) Ethyl trans-2-(3,4-dihydroxyphenyl) cyclopropane-carboxylate 0.00725424828633675 0.22091318
NSC 657822 (1R)-3,3-Dibromocamphor 0.00725424828633675 0.61618802
NSC 667722 Null 0.00725424828633675 -0.2950501
Total:88  Current:20    [First] [Prev] [Next] [Last]